SCHEMBL3511005

SCHEMBL3511005

CC(=O)Nc1nc(C)c(-c2csc(C(C)C)n2)s1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 8/20 1.00
PIK3CA P42336 2/20 1.00
PIK3CD O00329 1/20 1.00
PIK3CB P42338 1/20 1.00
PI4KB Q9UBF8 5/20 0.63
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
POLB P06746 1/20 0.61
KDM4E B2RXH2 2/20 0.59
ALDH1A1 P00352 2/20 0.59
MAPT P10636 2/20 0.59
HTT P42858 2/20 0.59
HSD17B10 Q99714 2/20 0.59
HPGD P15428 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
USP2 O75604 1/20 0.58
LMNA P02545 1/20 0.58
GAA P10253 1/20 0.58
ALOX15 P16050 1/20 0.58
TSHR P16473 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4534987 0.82 PIK3CG (1.00) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
SCHEMBL4523388 0.82 PIK3CG (0.69) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
SCHEMBL4523379 0.82 PIK3CG (0.69) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
SCHEMBL5960477 0.81 PIK3CG (0.73) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
SCHEMBL16882665 0.81 PIK3CG (0.73) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
SCHEMBL4523664 0.81 PI4KB (0.74) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
SCHEMBL2833123 0.80 PIK3CG (0.71) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
SCHEMBL29089046 0.80 PIK3CG (0.74) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
SCHEMBL4528096 0.79 PI4KB (0.69) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB
SCHEMBL2837166 0.79 PIK3CG (0.74) PIK3CGPIK3CAPIK3CDPIK3CBPI4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298286-A1 Organic Compounds NOVARTIS AG 2010-11-25 US disclosed
EP-2238134-A2 BIS-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS Novartis AG (CH) 2010-10-13 EP disclosed
WO-2009080705-A2 BIS-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS NOVARTIS AG (CH) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298286-A1 Organic Compounds PIK3CA, PI4KB, PIK3CB PIK3CG 9/4885PIK3CA 1/4885PIK3CD 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.